Calbee, Inc. - CLBEY

CLBEY Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
CLBEY	-9.6	-1.3	-7.1	-19.3	-15.4	-6.3	-19.0	-44.7	-45.7	-45.7
S&P 500	0.9	0.9	2.0	3.4	8.7	24.7	37.2	82.1	193.2	34153.9

Compare CLBEY with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	CLBEY
name	Calbee, Inc.
price	4.618
changes percentage	-9.6282
change	-0.492
day low	4.618
day high	5.11
year high	6.58
year low	4.5
market cap	2307841510
price avg 50	5.02372
price avg 200	5.340865
exchange	PNK
volume	522
avg volume	3311
open	5.11
previous close	None
eps	0.25
pe	18.47
earnings announcement	2025-02-06T02:30:00.000+0000
shares outstanding	499749136
timestamp	2025-01-21 20:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 80.3%

Overall Quarterly Financial Health: 53.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
revenue	303027000000	279315000000	8.49
gross profit	101959000000	90200000000	13.04
gross profit ratio	0.34	0.32	4.19
research and development expenses	3910000000	3681000000	6.22
operating expenses	74655000000	67967000000	9.84
interest income	445000000	140000000	217.86
interest expense	250000000	162000000	54.32
ebitda	43129000000	34147000000	26.30
ebitdaratio	0.14	0.13	11.16
operating income	27304000000	22233000000	22.81
operating income ratio	0.09	0.08	13.20
net income	19886000000	14772000000	34.62
net income ratio	0.07	0.05	24.09
eps	159.22	115.16	38.26

Overall Score of Annual Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 303,027 million in 2024 from 279,315 million in 2023 representing a change of 8.49%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 101,959 million in 2024 from 90,200 million in 2023 representing a change of 13.04%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 3,910 million in 2024 from 3,681 million in 2023 representing a change of 6.22%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 43,129 million in 2024 from 34,147 million in 2023 representing a change of 26.3%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 27,304 million in 2024 from 22,233 million in 2023 representing a change of 22.81%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 19,886 million in 2024 from 14,772 million in 2023 representing a change of 34.62%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 159.22 in 2024 from 159.22 in 2023 representing a change of 38.26%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 74,655 million in 2024 from 67,967 million in 2023 representing a change of 9.84%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
revenue	77656000000	75688000000	2.60
gross profit	27049000000	24320000000	11.22
gross profit ratio	0.35	0.32	8.40
research and development expenses	0	1045000000	-100.00
operating expenses	19375000000	20749000000	-6.62
interest income	108000000	161000000	-32.92
interest expense	87000000	95000000	-8.42
ebitda	10927000000	6900000000	58.36
ebitdaratio	0.14	0.09	54.35
operating income	7674000000	3571000000	114.90
operating income ratio	0.1	0.05	109.45
net income	7071000000	2721000000	159.87
net income ratio	0.09	0.04	153.28
eps	56.62	21.79	159.84

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 77,656 million in 2025Q1 from 75,688 million in 2024Q4 representing a change of 2.6%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 27,049 million in 2025Q1 from 24,320 million in 2024Q4 representing a change of 11.22%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 19,375 million in 2025Q1 from 20,749 million in 2024Q4 representing a change of -6.62%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Operating Income: Operating income increased to 7,674 million in 2025Q1 from 3,571 million in 2024Q4 representing a change of 114.9%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 7,071 million in 2025Q1 from 2,721 million in 2024Q4 representing a change of 159.87%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 56.62 in 2025Q1 from 56.62 in 2024Q4 representing a change of 159.84%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2025Q1 from 1,045 million in 2024Q4 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 10,927 million in 2025Q1 from 6,900 million in 2024Q4 representing a change of 58.36%. The decrease in EBITDA indicates declined operational efficiency and profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
total assets	292158000000	239095000000	22.19
total liabilities	91072000000	56409000000	61.45
total equity	201086000000	182686000000	10.07
cash and cash equivalents	44295000000	32167000000	37.70
short term investments	-207000000	-5006000000	95.86
long term investments	9968000000	7603000000	31.11
total current assets	127853000000	98970000000	29.18
total non current assets	164305000000	140122000000	17.26
total current liabilities	54475000000	45663000000	19.30
total non current liabilities	36597000000	10746000000	240.56
common stock	12046000000	12046000000	0.00
retained earnings	191706000000	178329000000	7.50
total debt	27035000000	1849000000	1362.14

Overall Score of Annual Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 292,158 million in 2024 from 239,095 million in 2023 representing a change of 22.19%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 201,086 million in 2024 from 182,686 million in 2023 representing a change of 10.07%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 44,295 million in 2024 from 32,167 million in 2023 representing a change of 37.7%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to -207 million in 2024 from -5,006 million in 2023 representing a change of 95.86%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 127,853 million in 2024 from 98,970 million in 2023 representing a change of 29.18%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 191,706 million in 2024 from 178,329 million in 2023 representing a change of 7.5%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 91,072 million in 2024 from 56,409 million in 2023 representing a change of 61.45%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 54,475 million in 2024 from 45,663 million in 2023 representing a change of 19.3%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 27,035 million in 2024 from 1,849 million in 2023 representing a change of 1362.14%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
total assets	308222000000	292158000000	5.50
total liabilities	103503000000	91069000000	13.65
total equity	204719000000	201086000000	1.81
cash and cash equivalents	34998000000	37719000000	-7.21
short term investments	9614000000	6576000000	46.20
long term investments	14345000000	3185000000	350.39
total current assets	128734000000	127853000000	0.69
total non current assets	179488000000	164305000000	9.24
total current liabilities	56758000000	54475000000	4.19
total non current liabilities	46745000000	36594000000	27.74
common stock	12046000000	12046000000	0.00
retained earnings	191769000000	191706000000	0.03
total debt	35985000000	27040000000	33.08

Overall Score of Quarterly Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 308,222 million in 2025Q1 from 292,158 million in 2024Q4 representing a change of 5.5%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 204,719 million in 2025Q1 from 201,086 million in 2024Q4 representing a change of 1.81%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 9,614 million in 2025Q1 from 6,576 million in 2024Q4 representing a change of 46.2%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 128,734 million in 2025Q1 from 127,853 million in 2024Q4 representing a change of 0.69%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 191,769 million in 2025Q1 from 191,706 million in 2024Q4 representing a change of 0.03%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 103,503 million in 2025Q1 from 91,069 million in 2024Q4 representing a change of 13.65%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 34,998 million in 2025Q1 from 37,719 million in 2024Q4 representing a change of -7.21%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 56,758 million in 2025Q1 from 54,475 million in 2024Q4 representing a change of 4.19%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 35,985 million in 2025Q1 from 27,040 million in 2024Q4 representing a change of 33.08%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
net change in cash	7426000000	-19378000000	138.32
operating cash flow	24350000000	19310000000	26.10
free cash flow	-6836000000	-7406000000	7.70
capital expenditure	-31186000000	-26716000000	-16.73
depreciation and amortization	12675000000	12026000000	5.40
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	-1571000000	1213000000	-229.51
inventory	1824000000	-4915000000	137.11
acquisitions net	0	-1555000000	100.00
investments in property plant and equipment	-30591000000	-26716000000	-14.50
net cash used for investing activites	-35307000000	-20329000000	-73.68
debt repayment	25041000000	-770000000	3352.08
common stock issued	0	0	NaN
common stock repurchased	-240000000	-11999000000	98.00
dividends paid	-6504000000	-6723000000	3.26
net cash used provided by financing activities	16850000000	-20004000000	184.23
cash at end of period	37718000000	30292000000	24.51
accounts receivables	-15768000000	-3987000000	-295.49
cash at beginning of period	30292000000	49670000000	-39.01

Overall Score of Annual Cashflow Statement

0.86 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 7,426 million in 2024 from -19,378 million in 2023 representing a change of 138.32%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 24,350 million in 2024 from 19,310 million in 2023 representing a change of 26.1%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to -6,836 million in 2024 from -7,406 million in 2023 representing a change of 7.7%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -31,186 million in 2024 from -26,716 million in 2023 representing a change of -16.73%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -15,768 million in 2024 from -3,987 million in 2023 representing a change of -295.49%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -6,504 million in 2024 from -6,723 million in 2023 representing a change of 3.26%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Accounts Payables: The absolute value of Accounts Payables increased to 1,571 million in 2024 from 1,213 million in 2023 representing a change of -229.51%. This indicates that the company has increased its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
operating cash flow	1541000000	20706000000	-92.56
free cash flow	-3173000000	15293000000	-120.75
capital expenditure	-4714000000	-5413000000	12.91
depreciation and amortization	3263000000	3329000000	-1.98
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	2963000000	2107000000	40.63
accounts payables	25000000	-248000000	110.08
inventory	-2212000000	2409000000	-191.82
acquisitions net	0	118000000	-100.00
investments in property plant and equipment	-4714000000	-5413000000	12.91
net cash used for investing activites	-7605000000	-6775000000	-12.25
debt repayment	9956000000	-2959000000	436.47
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-6884000000	-7000000	-98242.86
net cash used provided by financing activities	2559000000	-3888000000	165.82
net change in cash	34998000000	10684000000	227.57
cash at end of period	34998000000	37719000000	-7.21
cash at beginning of period	0	27035000000	-100.00

Overall Score of Quarterly Cashflow Statement

0.29 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 34,998 million in 2025Q1 from 10,684 million in 2024Q4 representing a change of 227.57%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Accounts Payables: The absolute value of Accounts Payables decreased to 25 million in 2025Q1 from 248 million in 2024Q4 representing a change of 110.08%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 1,541 million in 2025Q1 from 20,706 million in 2024Q4 representing a change of -92.56%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -3,173 million in 2025Q1 from 15,293 million in 2024Q4 representing a change of -120.75%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -4,714 million in 2025Q1 from -5,413 million in 2024Q4 representing a change of 12.91%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to 2,963 in 2025Q1 from 2,107 million in 2024Q4 representing a change of 40.63%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -6,884 million in 2025Q1 from -7 million in 2024Q4 representing a change of -98242.86%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-03-31	2023-03-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	2426.17	2177.48	11.42
net income per share	159.22	115.16	38.26
operating cash flow per share	194.96	150.54	29.51
free cash flow per share	-54.73	-57.74	5.20
cash per share	354.64	211.74	67.49
book value per share	1609.98	1424.18	13.05
tangible book value per share	1407.65	1222.02	15.19
shareholders equity per share	1535.24	1357.34	13.11
interest debt per share	218.5	15.68	1293.70
market cap	430403928558	355447622543	21.09
enterprise value	419724928558	325129622543	29.09
pe ratio	21.64	24.06	-10.05
price to sales ratio	1.42	1.27	11.61
pocfratio	17.68	18.41	-3.98
pfcf ratio	-62.96	-47.99	-31.18
pb ratio	2.24	2.04	9.95
ptb ratio	2.24	2.04	9.95
ev to sales	1.39	1.16	18.99
enterprise value over ebitda	9.72	9.34	4.12
ev to operating cash flow	17.24	16.84	2.37
ev to free cash flow	-61.4	-43.9	-39.86
earnings yield	0.05	0.04	11.18
free cash flow yield	-0.02	-0.02	23.77
debt to equity	0.14	0.01	1227.89
debt to assets	0.09	0.01	1096.80
net debt to ebitda	-0.25	-0.87	71.59
current ratio	2.35	2.17	8.29
interest coverage	108.64	137.24	-20.84
income quality	1.22	0.85	43.57
dividend yield	0.02	0.02	-20.11
payout ratio	0.33	0.46	-28.14
sales general and administrative to revenue	0.14	0.15	-7.23
research and ddevelopement to revenue	0.01	0.01	-2.09
intangibles to total assets	0.09	0.11	-20.25
capex to operating cash flow	1.28	1.38	-7.43
capex to revenue	0.1	0.1	7.60
capex to depreciation	2.46	2.22	10.75
stock based compensation to revenue	0	0	NaN
graham number	2345.16	1875.37	25.05
roic	0.08	0.08	1.92
return on tangible assets	0.07	0.07	7.52
graham net net	38.89	79.4	-51.03
working capital	73378000000	53307000000	37.65
tangible asset value	175815000000	156754000000	12.16
net current asset value	36781000000	42561000000	-13.58
invested capital	222306000000	180772000000	22.98
average receivables	45525000000	34793000000	30.85
average payables	13044000000	12701000000	2.70
average inventory	22780000000	20676500000	10.17
days sales outstanding	65.09	48.36	34.59
days payables outstanding	22.74	26.16	-13.07
days of inventory on hand	40.29	45.07	-10.61
receivables turnover	5.61	7.55	-25.70
payables turnover	16.05	13.95	15.03
inventory turnover	9.06	8.1	11.87
roe	0.1	0.08	22.24
capex per share	249.69	208.27	19.89

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 21.64 on 2024-03-31 from 24.06 on 2023-03-31, representing a change of -10.05%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 2.35 on 2024-03-31 from 2.17 on 2023-03-31, representing a change of 8.29%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.14 on 2024-03-31 from 0.01 on 2023-03-31, representing a change of 1227.89%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q2	2024-06-30 Q1	Q/Q change %
CLBEY
calendar year	2024	2024	NaN
revenue per share	635.62	621.85	2.22
net income per share	28.51	56.62	-49.65
operating cash flow per share	206.92	12.34	1576.82
free cash flow per share	62.07	-25.41	344.29
cash per share	412.51	357.24	15.47
book value per share	1632.73	1639.33	-0.40
tangible book value per share	1440.97	1434.99	0.42
shareholders equity per share	1555.72	1557.98	-0.15
interest debt per share	296.19	288.85	2.54
market cap	436410592674	386251677993	12.99
enterprise value	421789592674	387238677993	8.92
pe ratio	30.63	13.66	124.29
price to sales ratio	5.5	4.97	10.48
pocfratio	16.88	250.65	-93.27
pfcf ratio	56.27	-121.73	146.23
pb ratio	2.25	1.99	13.10
ptb ratio	2.25	1.99	13.10
ev to sales	5.31	4.99	6.51
enterprise value over ebitda	47.47	35.44	33.94
ev to operating cash flow	16.32	251.29	-93.51
ev to free cash flow	54.39	-122.04	144.57
earnings yield	0.01	0.02	-55.42
free cash flow yield	0.02	-0.01	316.32
debt to equity	0.19	0.18	2.69
debt to assets	0.12	0.12	5.13
net debt to ebitda	-1.65	0.09	-1921.61
current ratio	2.42	2.27	6.69
interest coverage	81.35	88.09	-7.66
income quality	7.26	0.22	3230.26
dividend yield	0.0	0.02	-98.48
payout ratio	0.03	0.97	-96.60
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.08	0.08	-3.79
capex to operating cash flow	0.7	3.06	-77.12
capex to revenue	0.23	0.06	275.40
capex to depreciation	5.46	1.44	277.88
stock based compensation to revenue	0	0	NaN
graham number	998.98	1408.86	-29.09
roic	0.02	0.02	-20.57
return on tangible assets	0.01	0.03	-48.55
graham net net	-28.31	-61.56	54.01
working capital	71400000000	71976000000	-0.80
tangible asset value	180033000000	179201000000	0.46
net current asset value	24902000000	25231000000	-1.30
invested capital	237072000000	237117000000	-0.02
average receivables	44699500000	52893500000	-15.49
average payables	14745000000	12697000000	16.13
average inventory	25866500000	23497000000	10.08
days sales outstanding	42.67	59.97	-28.85
days payables outstanding	28.46	22.87	24.45
days of inventory on hand	46.11	44.08	4.61
receivables turnover	2.11	1.5	40.55
payables turnover	3.16	3.94	-19.64
inventory turnover	1.95	2.04	-4.41
roe	0.02	0.04	-49.58
capex per share	144.85	37.75	283.72

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-09-30 Q2 from 0.04 on 2024-06-30 Q1, representing a change of -49.58%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 30.63 on 2024-09-30 Q2 from 13.66 on 2024-06-30 Q1, representing a change of 124.29%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 2.42 on 2024-09-30 Q2 from 2.27 on 2024-06-30 Q1, representing a change of 6.69%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.19 on 2024-09-30 Q2 from 0.18 on 2024-06-30 Q1, representing a change of 2.69%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None